QSS
ATRA icon

Quantitative Systematic Strategies’s Atara Biotherapeutics ATRA Stock Holding History

Quantitative Systematic Strategies’s Portfolio ATRA Stock Details ATRA Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2020
Q4 		– Sell
-427
Closed -$138K – 608
2020
Q3 		$138K Sell
427
-11
-3% -$3.75K 0.02% 550
2020
Q2 		$160K Buy
+438
New +$111K 0.03% 534
2019
Q1 		– Sell
-500
Closed -$434K – 401
2018
Q4 		$434K Buy
+500
New +$464K 0.1% 300
2016
Q1 		– Sell
-480
Closed -$321K – 433
2015
Q4 		$321K Buy
480
+206
+75% +$156K 0.09% 314
2015
Q3 		$214K Buy
+274
New +$334K 0.11% 327

Other funds holding ATRA

BG
Baupost Group Boston, Massachusetts $5.42B AUM 22.93% 1-Year Est. Return
MC
Maverick Capital Dallas, Texas $11.3B AUM 76.6% 1-Year Est. Return
RG
Redmile Group San Francisco, California $1.49B AUM 208.7% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
JP Morgan Chase
JP Morgan Chase New York $1.81T AUM 41.13% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return
CCM
Consonance Capital Management New York $7.28M AUM 43.59% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
AG
Artal Group Luxembourg $931M AUM 41.63% 1-Year Est. Return

Quantitative Systematic Strategies's ATRA Position: Q4 2020 in Review

Quantitative Systematic Strategies sold out of Atara Biotherapeutics (ATRA) in Q4 2020, closing a stake of 427 shares — an estimated $138K sold.

Quantitative Systematic Strategies first reported a position in ATRA in Q3 2015 and held it in 5 quarters. The position peaked at $434K in Q4 2018. 148 funds tracked by Wall St. Rank hold ATRA as of Q4 2020.

  • Quantitative Systematic Strategies reported no remaining Atara Biotherapeutics position as of Q4 2020 after selling out during the quarter.
  • Quantitative Systematic Strategies sold 427 Atara Biotherapeutics shares in Q4 2020, an estimated $138K.
  • Quantitative Systematic Strategies first reported a position in Atara Biotherapeutics in Q3 2015 and held it in 5 quarters.
  • Quantitative Systematic Strategies's Atara Biotherapeutics position peaked at $434K in Q4 2018.
  • 148 funds tracked by Wall St. Rank held Atara Biotherapeutics as of Q4 2020.

Based on Quantitative Systematic Strategies's 13F filing for Q4 2020, filed 9 Feb 2021.